Yahoo
NasdaqCM - Delayed Quote USD

Abeona Therapeutics Inc. (ABEO)

6.00 +0.07 (+1.18%)
At close: September 4 at 4:00:01 PM EDT
6.00 0.00 (0.00%)
After hours: September 4 at 7:30:03 PM EDT
Trade ABEO on Coinbase
Chart Range Bar
Loading chart for ABEO
  • Previous Close 5.93
  • Open 5.89
  • Bid 4.25 x 200
  • Ask 7.53 x 200
  • Day's Range 5.85 - 6.02
  • 52 Week Range 4.00 - 7.65
  • Volume 866,459
  • Avg. Volume 1,390,558
  • Market Cap (intraday) 343.104M
  • Beta (5Y Monthly) 1.32
  • PE Ratio (TTM) --
  • EPS (TTM) -1.21
  • Earnings Date Nov 11, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 18.86

Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.

www.abeonatherapeutics.com

226

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ABEO
13.85%
S&P 500 (^GSPC)
12.75%

1-Year Return

ABEO
12.54%
S&P 500 (^GSPC)
18.71%

3-Year Return

ABEO
43.20%
S&P 500 (^GSPC)
70.93%

5-Year Return

ABEO
82.22%
S&P 500 (^GSPC)
70.18%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 8.72M
Earnings -17.07M
Profit Margin -195.81%

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
50M
100M
0.0%
5000.0%
10000.0%
15000.0%
20000.0%
25000.0%

Analyst Insights

View More

Analyst Price Targets

14.00
18.86 Average
6.00 Current
28.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/14/2026
Analyst Oppenheimer
Rating Action Maintains
Rating Outperform
Price Action Lowers
Price Target 22 -> 21

Statistics

View More

Valuation Measures

Annual
As of 8/12/2026
  • Market Cap

    341.10M

  • Enterprise Value

    214.15M

  • Trailing P/E

    7.86

  • Forward P/E

    526.32

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    14.52

  • Price/Book (mrq)

    2.67

  • Enterprise Value/Revenue

    8.41

  • Enterprise Value/EBITDA

    3.82

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -246.42%

  • Return on Assets (ttm)

    -24.55%

  • Return on Equity (ttm)

    -43.13%

  • Revenue (ttm)

    25.52M

  • Net Income Avi to Common (ttm)

    -62.89M

  • Diluted EPS (ttm)

    -1.21

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    146.83M

  • Total Debt/Equity (mrq)

    15.52%

  • Levered Free Cash Flow (ttm)

    -73.4M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

6.00 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Daily – Vickers Top Buyers & Sellers for 07/23/2026

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 07/10/2026

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 07/11/2025

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: